cyclosporine has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gronkowska, A; Lakomy, M; Michalewska, B; Pogorzala, M; Rokicka, M; Styczynski, J; Tomaszewska, A; Torosian, T; Wiktor-Jedrzejczak, W; Wysocki, M | 1 |
| Goto, T; Koike, K; Kurokawa, M; Yamamoto, G; Yoshimi, A | 1 |
| Bungey, J; Cross, NC; Feng, L; Ferrant, A; Goldman, JM; Hughes, TP; Marks, DI; Martiat, P; O'Shea, P | 1 |
| Batlle, M; Fernández-Avilés, F; Lauzurica, R; Ribera, JM | 1 |
| Bandini, G; Bonini, A; Campanini, E; Mangianti, S; Motta, MR; Remiddi, C; Rizzi, S; Rondelli, D; Rosti, G; Testoni, N; Tura, S; Zuffa, E | 1 |
| Drobyski, WR; Hessner, MJ; Kabler-Babbitt, C; Keever-Taylor, CA; Klein, JP; Margolis, DA; Vesole, DH | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
| Geller, RB; Griffin, C; Piantadosi, S; Saral, R; Shah, N; Vogelsang, GB; Wagner, JE; Wingard, JR; Zahurak, M; Zehnbauer, BA | 1 |
| Goldman, JM | 1 |
2 review(s) available for cyclosporine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Postoperative Complications; Prednisolone | 2012 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
2 trial(s) available for cyclosporine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
6 other study(ies) available for cyclosporine and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Antineoplastic Agents; Benzamides; Cord Blood Stem Cell Transplantation; Cyclosporine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Piperazines; Pyrimidines; Splenectomy; Transfusion Reaction; Transplantation Conditioning; Young Adult | 2009 |
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.
Topics: Acute Disease; Base Sequence; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Postoperative Period; Transplantation, Homologous | 1993 |
[Chronic myeloid leukemia after kidney transplantation].
Topics: Adult; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Postoperative Complications | 1997 |
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 1998 |
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Gastrointestinal Hemorrhage; Graft Enhancement, Immunologic; Graft vs Host Disease; Graft vs Tumor Effect; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocyte Transfusion; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neoplasm, Residual; Nuclear Family; Polymerase Chain Reaction; Salvage Therapy; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
Topics: Adolescent; Adult; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Whole-Body Irradiation | 1992 |